Geriatric Care Model for Dialysis
Trial Summary
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the Geriatric Care Model treatment for dialysis patients?
Research suggests that tailoring dialysis treatment plans to address geriatric impairments (age-related health issues) can improve outcomes for older patients. By being aware of these impairments, healthcare providers can make better decisions that may enhance the care and quality of life for elderly patients on dialysis.12345
Is the Geriatric Care Model for Dialysis safe for humans?
The research highlights that older adults, especially those with multiple health issues, are at higher risk for adverse drug reactions and events. However, careful management and consultation with specialists can help reduce these risks, suggesting that with proper care, the Geriatric Care Model can be safe for use in humans.678910
How is the Geriatric Care Model treatment for dialysis unique?
The Geriatric Care Model for dialysis is unique because it focuses on addressing the specific needs of older adults with kidney failure, incorporating a comprehensive geriatric assessment to manage not just kidney issues but also other age-related health problems. This approach aims to improve overall health and quality of life by considering the complex health challenges faced by elderly patients on dialysis.45111213
What is the purpose of this trial?
The objectives of this study are to refine the dialysis care model with key stakeholder input and conduct a pilot randomized controlled trial (RCT) to obtain evidence critical to inform a definitive RCT.
Research Team
Rasheeda K Hall, MD, MBA, MHS, FASN
Principal Investigator
Duke University
Eligibility Criteria
This trial is for community-dwelling dialysis patients aged 55 and older, who may have some cognitive impairment. Those with severe cognitive issues can join if they have a caregiver present to assist them during the study.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Refinement Aim 1
Participants complete the care model and undergo geriatric evaluation
Refinement Aim 2
Assessment of acceptability and feasibility of the care model through surveys and interviews
Pilot RCT
Conduct pilot RCT comparing geriatric care model vs. usual care and assess outcomes
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Geriatric Care Model
- Usual Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor
University of California, San Francisco
Collaborator